PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.58
ESG score 80-90% of SGMO's 66.81. Walter Schloss would scrutinize governance quality and regulatory exposure.
59.17
Environmental score 90-95% of SGMO's 64.06. Bill Ackman would demand clear environmental improvement catalysts.
59.13
Social score 80-90% of SGMO's 71.19. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
60.43
Governance score 90-95% of SGMO's 65.19. Bill Ackman would demand clear governance improvement catalysts.